U.S. flag An official website of the United States government
  1. Home
  2. Drug Databases
  3. Drugs@FDA

Drugs@FDA: FDA-Approved Drugs

Home | Previous Page

New Drug Application (NDA): 204819
Company: BAYER HLTHCARE
Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status TE Code RLD RS
ADEMPAS RIOCIGUAT 0.5MG TABLET;ORAL Prescription AB Yes No
ADEMPAS RIOCIGUAT 1MG TABLET;ORAL Prescription AB Yes No
ADEMPAS RIOCIGUAT 1.5MG TABLET;ORAL Prescription AB Yes No
ADEMPAS RIOCIGUAT 2MG TABLET;ORAL Prescription AB Yes No
ADEMPAS RIOCIGUAT 2.5MG TABLET;ORAL Prescription AB Yes Yes
Original Approvals or Tentative Approvals
Action Date Submission Action Type Submission Classification Review Priority; Orphan Status Letters, Reviews, Labels, Patient Package Insert Notes Url
10/08/2013 ORIG-1 Approval Type 1 - New Molecular Entity STANDARD; Orphan Label (PDF)
Letter (PDF)
Review
Summary Review (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204819s000lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2013/204819Orig1s000ltr.pdf https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/204819Orig1s000TOC.cfm https://www.accessdata.fda.gov/drugsatfda_docs/nda/2013/204819Orig1s000SumR.pdf
Supplements
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels, Patient Package Insert Note Url
09/10/2021 SUPPL-15 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204819s015lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2021/204819Orig1s015ltr.pdf
02/10/2020 SUPPL-14 REMS - MODIFIED - D-N-A Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/204819Orig1s014ltr.pdf
11/30/2020 SUPPL-13 REMS - MODIFIED - BIFURCATED, REMS - MODIFIED - D-N-A Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2020/204819Orig1s013ltr.pdf
01/11/2018 SUPPL-11 Efficacy-Labeling Change With Clinical Data Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204819s011lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/204819Orig1s011ltr.pdf
12/06/2018 SUPPL-9 REMS - MODIFIED - D-N-A Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2018/204819s009ltr.pdf
02/23/2017 SUPPL-8 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204819s008lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/204819Orig1s008ltr.pdf
10/04/2016 SUPPL-7 REMS - MODIFIED - D-N-A Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2016/204819Orig1s007ltr.pdf
01/17/2017 SUPPL-6 REMS - MODIFIED - D-N-A Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204819s006lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2017/204819Orig1s006ltr.pdf
12/04/2015 SUPPL-4 REMS-Modified Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2015/204819Orig1s004ltr.pdf
02/23/2015 SUPPL-3 Manufacturing (CMC)

Label is not available on this site.

05/06/2014 SUPPL-2 Labeling-Package Insert Label (PDF)
Letter (PDF)
https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204819s002lbl.pdf https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/204819Orig1s002ltr.pdf
06/11/2014 SUPPL-1 REMS-Modified Letter (PDF)

Label is not available on this site.

https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2014/204819Orig1s001ltr.pdf
Action Date Submission Supplement Categories or Approval Type Letters, Reviews, Labels,
Patient Package Insert
Note Url
09/10/2021 SUPPL-15 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2021/204819s015lbl.pdf
01/11/2018 SUPPL-11 Efficacy-Labeling Change With Clinical Data Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2018/204819s011lbl.pdf
02/23/2017 SUPPL-8 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204819s008lbl.pdf
01/17/2017 SUPPL-6 REMS - MODIFIED - D-N-A Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2017/204819s006lbl.pdf
05/06/2014 SUPPL-2 Labeling-Package Insert Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2014/204819s002lbl.pdf
10/08/2013 ORIG-1 Approval Label (PDF) https://www.accessdata.fda.gov/drugsatfda_docs/label/2013/204819s000lbl.pdf

ADEMPAS

TABLET;ORAL; 0.5MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ADEMPAS RIOCIGUAT 0.5MG TABLET;ORAL Prescription Yes AB 204819 BAYER HLTHCARE
RIOCIGUAT RIOCIGUAT 0.5MG TABLET;ORAL Prescription No AB 211135 MSN

TABLET;ORAL; 1MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ADEMPAS RIOCIGUAT 1MG TABLET;ORAL Prescription Yes AB 204819 BAYER HLTHCARE
RIOCIGUAT RIOCIGUAT 1MG TABLET;ORAL Prescription No AB 211135 MSN

TABLET;ORAL; 1.5MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ADEMPAS RIOCIGUAT 1.5MG TABLET;ORAL Prescription Yes AB 204819 BAYER HLTHCARE
RIOCIGUAT RIOCIGUAT 1.5MG TABLET;ORAL Prescription No AB 211135 MSN

TABLET;ORAL; 2MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ADEMPAS RIOCIGUAT 2MG TABLET;ORAL Prescription Yes AB 204819 BAYER HLTHCARE
RIOCIGUAT RIOCIGUAT 2MG TABLET;ORAL Prescription No AB 211135 MSN

TABLET;ORAL; 2.5MG
TE Code = AB

Drug Name Active Ingredients Strength Dosage Form/Route Marketing Status RLD TE Code Application No. Company
ADEMPAS RIOCIGUAT 2.5MG TABLET;ORAL Prescription Yes AB 204819 BAYER HLTHCARE
RIOCIGUAT RIOCIGUAT 2.5MG TABLET;ORAL Prescription No AB 211135 MSN
Back to Top